Envoy Medical Ownership 2024 | Who Owns Envoy Medical Now?


OverviewRevenueFinancialsChart

Institutional Ownership

28.27%

0

Institutional Holders

16.00

Envoy Medical Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DEUTSCHE BANK AG\----197,699-100.00%-Dec 31, 2023
FIR TREE CAPITAL MANAGEMENT LP----247,635-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----14,692-100.00%-Dec 31, 2023
POLAR ASSET MANAGEMENT PARTNERS INC.----200,000-100.00%-Dec 31, 2023
WEISS ASSET MANAGEMENT LP----20,000-100.00%-Dec 31, 2023
RIVERNORTH CAPITAL MANAGEMENT, LLC----52,647-100.00%-Dec 31, 2023
MOORE CAPITAL MANAGEMENT, LP----50,000-100.00%-Dec 31, 2023
TWO SIGMA SECURITIES, LLC----12,224-100.00%-Dec 31, 2023
FLOW TRADERS U.S. LLC----12,462-100.00%-Dec 31, 2023
WESTCHESTER CAPITAL MANAGEMENT, LLC----108,000-100.00%-Dec 31, 2023
ROBINSON CAPITAL MANAGEMENT, LLC----85,400-100.00%-Dec 31, 2023
TOROSO INVESTMENTS, LLC----50,000-100.00%-Dec 31, 2023
CLEAR STREET LLC----127,000-100.00%-Dec 31, 2023
SANDIA INVESTMENT MANAGEMENT LP----500,000-100.00%-Dec 31, 2023
METEORA CAPITAL, LLC----425,606-100.00%-Dec 31, 2023
ATLAS MERCHANT CAPITAL LLC----900,000-100.00%-Dec 31, 2023

Envoy Medical's largest institutional shareholder is DEUTSCHE BANK AG\, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DEUTSCHE BANK AG\----197,699-100.00%-Dec 31, 2023
FIR TREE CAPITAL MANAGEMENT LP----247,635-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----14,692-100.00%-Dec 31, 2023
POLAR ASSET MANAGEMENT PARTNERS INC.----200,000-100.00%-Dec 31, 2023
WEISS ASSET MANAGEMENT LP----20,000-100.00%-Dec 31, 2023
RIVERNORTH CAPITAL MANAGEMENT, LLC----52,647-100.00%-Dec 31, 2023
MOORE CAPITAL MANAGEMENT, LP----50,000-100.00%-Dec 31, 2023
TWO SIGMA SECURITIES, LLC----12,224-100.00%-Dec 31, 2023
FLOW TRADERS U.S. LLC----12,462-100.00%-Dec 31, 2023
WESTCHESTER CAPITAL MANAGEMENT, LLC----108,000-100.00%-Dec 31, 2023
ROBINSON CAPITAL MANAGEMENT, LLC----85,400-100.00%-Dec 31, 2023
TOROSO INVESTMENTS, LLC----50,000-100.00%-Dec 31, 2023
CLEAR STREET LLC----127,000-100.00%-Dec 31, 2023
SANDIA INVESTMENT MANAGEMENT LP----500,000-100.00%-Dec 31, 2023
METEORA CAPITAL, LLC----425,606-100.00%-Dec 31, 2023
ATLAS MERCHANT CAPITAL LLC----900,000-100.00%-Dec 31, 2023

The largest Envoy Medical shareholder by % of total assets is DEUTSCHE BANK AG\. The company owns 0.00 shares of Envoy Medical (ANZU), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
TWO SIGMA SECURITIES, LLC----12,224-100.00%-Dec 31, 2023
FLOW TRADERS U.S. LLC----12,462-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----14,692-100.00%-Dec 31, 2023
WEISS ASSET MANAGEMENT LP----20,000-100.00%-Dec 31, 2023
TOROSO INVESTMENTS, LLC----50,000-100.00%-Dec 31, 2023
MOORE CAPITAL MANAGEMENT, LP----50,000-100.00%-Dec 31, 2023
RIVERNORTH CAPITAL MANAGEMENT, LLC----52,647-100.00%-Dec 31, 2023
ROBINSON CAPITAL MANAGEMENT, LLC----85,400-100.00%-Dec 31, 2023
WESTCHESTER CAPITAL MANAGEMENT, LLC----108,000-100.00%-Dec 31, 2023
CLEAR STREET LLC----127,000-100.00%-Dec 31, 2023
DEUTSCHE BANK AG\----197,699-100.00%-Dec 31, 2023
POLAR ASSET MANAGEMENT PARTNERS INC.----200,000-100.00%-Dec 31, 2023
FIR TREE CAPITAL MANAGEMENT LP----247,635-100.00%-Dec 31, 2023
METEORA CAPITAL, LLC----425,606-100.00%-Dec 31, 2023
SANDIA INVESTMENT MANAGEMENT LP----500,000-100.00%-Dec 31, 2023
ATLAS MERCHANT CAPITAL LLC----900,000-100.00%-Dec 31, 2023

As of Dec 31 2023, Envoy Medical's largest institutional buyer is TWO SIGMA SECURITIES, LLC. The company purchased -12.22K stocks of ANZU, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ATLAS MERCHANT CAPITAL LLC----900,000-100.00%-Dec 31, 2023
SANDIA INVESTMENT MANAGEMENT LP----500,000-100.00%-Dec 31, 2023
METEORA CAPITAL, LLC----425,606-100.00%-Dec 31, 2023
FIR TREE CAPITAL MANAGEMENT LP----247,635-100.00%-Dec 31, 2023
POLAR ASSET MANAGEMENT PARTNERS INC.----200,000-100.00%-Dec 31, 2023
DEUTSCHE BANK AG\----197,699-100.00%-Dec 31, 2023
CLEAR STREET LLC----127,000-100.00%-Dec 31, 2023
WESTCHESTER CAPITAL MANAGEMENT, LLC----108,000-100.00%-Dec 31, 2023
ROBINSON CAPITAL MANAGEMENT, LLC----85,400-100.00%-Dec 31, 2023
RIVERNORTH CAPITAL MANAGEMENT, LLC----52,647-100.00%-Dec 31, 2023
MOORE CAPITAL MANAGEMENT, LP----50,000-100.00%-Dec 31, 2023
TOROSO INVESTMENTS, LLC----50,000-100.00%-Dec 31, 2023
WEISS ASSET MANAGEMENT LP----20,000-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----14,692-100.00%-Dec 31, 2023
FLOW TRADERS U.S. LLC----12,462-100.00%-Dec 31, 2023
TWO SIGMA SECURITIES, LLC----12,224-100.00%-Dec 31, 2023

As of Dec 31 2023, Envoy Medical's biggest institutional seller is ATLAS MERCHANT CAPITAL LLC. The company sold -0.90M shares of ANZU, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ATLAS MERCHANT CAPITAL LLC----900,000-100.00%-Dec 31, 2023
SANDIA INVESTMENT MANAGEMENT LP----500,000-100.00%-Dec 31, 2023
METEORA CAPITAL, LLC----425,606-100.00%-Dec 31, 2023
FIR TREE CAPITAL MANAGEMENT LP----247,635-100.00%-Dec 31, 2023
POLAR ASSET MANAGEMENT PARTNERS INC.----200,000-100.00%-Dec 31, 2023
DEUTSCHE BANK AG\----197,699-100.00%-Dec 31, 2023
CLEAR STREET LLC----127,000-100.00%-Dec 31, 2023
WESTCHESTER CAPITAL MANAGEMENT, LLC----108,000-100.00%-Dec 31, 2023
ROBINSON CAPITAL MANAGEMENT, LLC----85,400-100.00%-Dec 31, 2023
RIVERNORTH CAPITAL MANAGEMENT, LLC----52,647-100.00%-Dec 31, 2023
MOORE CAPITAL MANAGEMENT, LP----50,000-100.00%-Dec 31, 2023
TOROSO INVESTMENTS, LLC----50,000-100.00%-Dec 31, 2023
WEISS ASSET MANAGEMENT LP----20,000-100.00%-Dec 31, 2023
GEODE CAPITAL MANAGEMENT, LLC----14,692-100.00%-Dec 31, 2023
FLOW TRADERS U.S. LLC----12,462-100.00%-Dec 31, 2023
TWO SIGMA SECURITIES, LLC----12,224-100.00%-Dec 31, 2023

Envoy Medical's largest sold out institutional shareholder by shares sold is ATLAS MERCHANT CAPITAL LLC, sold -0.90M shares, valued at -, as of undefined.

Envoy Medical Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
Keeley Funds, Inc.0.08%19,790--Dec 29, 2023
Investment Managers Series Trust II0.03%358,814--Jan 31, 2024
MERGER FUND0.01%99,143--Mar 28, 2024
RIVERPARK FUNDS TRUST0.01%98,738--Dec 31, 2023
MERGER FUND VL0.01%1,238--Mar 28, 2024
Saba Capital Income & Opportunities Fund0.01%18,438--Jan 31, 2024
Tidal ETF Trust0.00%50,000--Jan 31, 2024
Weiss Strategic Interval Fund0.00%11,39811,398-Sep 30, 2022
CALAMOS INVESTMENT TRUST/IL0.00%300,000--Jan 31, 2024
Virtus Event Opportunities Trust0.00%2,298--Mar 28, 2024
Blackstone Alternative Investment Funds0.00%46,634--Mar 31, 2023
Brinker Capital Destinations Trust0.00%42,449--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%17,543--Feb 29, 2024
Franklin Alternative Strategies Funds0.00%32,745--Feb 29, 2024
Investment Managers Series Trust0.00%20,000--Mar 31, 2024
TRUST FOR PROFESSIONAL MANAGERS0.00%1,458--Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%272--Jan 31, 2024
PRINCIPAL FUNDS, INC.0.00%7,732--Feb 29, 2024
AQR Funds0.00%257,365--Mar 31, 2024

Envoy Medical's largest mutual fund holder by % of total assets is "Keeley Funds, Inc.", owning 19.79K shares, compromising 0.08% of its total assets.

Envoy Medical Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Sep, 2316-20.00%
30 Jun, 2320-16.67%
31 Mar, 2324-74.74%
31 Dec, 2295-
30 Sep, 22957.95%
30 Jun, 22886.02%
31 Mar, 22835.06%
31 Dec, 217917.91%
30 Sep, 216717.54%
30 Jun, 2157-

As of 30 Sep 23, 16 institutions are holding Envoy Medical's shares, representing a decrease of -20.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Sep, 233,003,365-24.36%
30 Jun, 233,970,740-3.43%
31 Mar, 234,111,608-88.87%
31 Dec, 2236,953,012-0.11%
30 Sep, 2236,994,7488.47%
30 Jun, 2234,105,6853.22%
31 Mar, 2233,040,2671.40%
31 Dec, 2132,584,78835.37%
30 Sep, 2124,070,60810.61%
30 Jun, 2121,762,158-

Envoy Medical (ANZU) has 3.00M shares outstanding as of 30 Sep 23, down -24.36% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Sep, 2328.27%32.41%
30 Jun, 239.34%9.99%
31 Mar, 239.67%0.13%
31 Dec, 2286.95%1.15%
30 Sep, 2287.05%2.11%
30 Jun, 2264.20%1.66%
31 Mar, 2262.19%1.23%
31 Dec, 2171.12%3.46%
30 Sep, 2145.31%2.70%
30 Jun, 2140.96%-

As of 30 Sep 23, Envoy Medical is held by 28.27% institutional shareholders, representing a 32.41% growth compared to 30 Jun 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Sep, 237-22.22%
30 Jun, 239-40.00%
31 Mar, 2315-58.33%
31 Dec, 2236-5.26%
30 Sep, 223865.22%
30 Jun, 222321.05%
31 Mar, 2219-40.63%
31 Dec, 213228.00%
30 Sep, 2125-56.14%
30 Jun, 2157-

7 institutional shareholders have increased their position in ANZU stock as of 30 Sep 23 compared to 9 in the previous quarter (a -22.22% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Sep, 23350.00%
30 Jun, 232-71.43%
31 Mar, 237-46.15%
31 Dec, 221385.71%
30 Sep, 227-22.22%
30 Jun, 229-25.00%
31 Mar, 22129.09%
31 Dec, 2111266.67%
30 Sep, 213-
30 Jun, 21--

3 institutional shareholders have reduced their position in ANZU stock as of 30 Sep 23 compared to 2 in the previous quarter (a 50.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Sep, 2316-20.00%3,003,365-24.36%28.27%32.41%7-22.22%350.00%
30 Jun, 2320-16.67%3,970,740-3.43%9.34%9.99%9-40.00%2-71.43%
31 Mar, 2324-74.74%4,111,608-88.87%9.67%0.13%15-58.33%7-46.15%
31 Dec, 2295-36,953,012-0.11%86.95%1.15%36-5.26%1385.71%
30 Sep, 22957.95%36,994,7488.47%87.05%2.11%3865.22%7-22.22%
30 Jun, 22886.02%34,105,6853.22%64.20%1.66%2321.05%9-25.00%
31 Mar, 22835.06%33,040,2671.40%62.19%1.23%19-40.63%129.09%
31 Dec, 217917.91%32,584,78835.37%71.12%3.46%3228.00%11266.67%
30 Sep, 216717.54%24,070,60810.61%45.31%2.70%25-56.14%3-
30 Jun, 2157-21,762,158-40.96%-57---

Envoy Medical Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Nov 24, 2023Lucas Brent T.director, officer Chief Executive OfficerP-PurchaseBuy2,380$0.92$2.19K120,831
Nov 24, 2023Lucas Brent T.director, officer Chief Executive OfficerP-PurchaseBuy10,000$0.98$9.80K118,451
Nov 22, 2023TAYLOR GLEN Adirector, 10 percent owner P-PurchaseBuy100,000$11.50$1.15M1,100,000
Oct 03, 2023Anzu SPAC GP I LLC10 percent owner-P-PurchaseBuy1,000,000$11.50$11.50M1,000,000

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Nov 24, 2023Lucas Brent T.director, officer Chief Executive OfficerP-PurchaseBuy2,380$0.92$2.19K120,831
Nov 24, 2023Lucas Brent T.director, officer Chief Executive OfficerP-PurchaseBuy10,000$0.98$9.80K118,451
Nov 22, 2023TAYLOR GLEN Adirector, 10 percent owner P-PurchaseBuy100,000$11.50$1.15M1,100,000
Oct 03, 2023Anzu SPAC GP I LLC10 percent owner-P-PurchaseBuy1,000,000$11.50$11.50M1,000,000

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Dec 04, 2023TAYLOR GLEN Adirector, 10 percent owner J-OtherSell100,000$11.50$1.15M1,000,000
Oct 03, 2023Anzu SPAC GP I LLC10 percent owner-D-ReturnSell5,510,000--4,990,000
Oct 03, 2023Anzu SPAC GP I LLC10 percent owner-J-OtherSell2,500,000--2,490,000
Oct 03, 2023Anzu SPAC GP I LLC10 percent owner-J-OtherSell490,000--2,000,000
Oct 03, 2023Anzu SPAC GP I LLC10 percent owner-C-ConversionSell2,490,000---
Oct 03, 2023Huskins Priya Cheriandirector-C-ConversionSell25,000---

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Dec 04, 2023TAYLOR GLEN Adirector, 10 percent owner J-OtherSell100,000$11.50$1.15M1,000,000
Nov 24, 2023Lucas Brent T.director, officer Chief Executive OfficerP-PurchaseBuy2,380$0.92$2.19K120,831
Nov 24, 2023Lucas Brent T.director, officer Chief Executive OfficerP-PurchaseBuy10,000$0.98$9.80K118,451
Nov 22, 2023TAYLOR GLEN Adirector, 10 percent owner P-PurchaseBuy100,000$11.50$1.15M1,100,000
Oct 17, 2023Kantor Susandirector-A-AwardBuy62,500$2.40$150.00K62,500
Oct 17, 2023Lucas Brent T.director, officer Chief Executive OfficerA-AwardBuy879,749$2.40$2.11M879,749
Oct 17, 2023BRYNELSEN CHARLESdirector-A-AwardBuy62,500$2.40$150.00K62,500
Oct 17, 2023Patel Mona Chetandirector-A-AwardBuy25,000$2.40$60.00K25,000
Oct 17, 2023Wells David R.officer Chief Financial OfficerA-AwardBuy293,250$2.40$703.80K293,250
Oct 17, 2023Smith-Gomez Janisdirector-A-AwardBuy25,000$2.40$60.00K25,000
Oct 03, 2023Anzu SPAC GP I LLC10 percent owner-D-ReturnSell5,510,000--4,990,000
Oct 03, 2023Anzu SPAC GP I LLC10 percent owner-J-OtherBuy2,500,000$11.50$28.75M2,500,000
Oct 03, 2023Anzu SPAC GP I LLC10 percent owner-C-ConversionBuy2,490,000-$249.002,490,000
Oct 03, 2023Anzu SPAC GP I LLC10 percent owner-J-OtherSell2,500,000--2,490,000
Oct 03, 2023Anzu SPAC GP I LLC10 percent owner-J-OtherSell490,000--2,000,000
Oct 03, 2023Anzu SPAC GP I LLC10 percent owner-P-PurchaseBuy1,000,000$11.50$11.50M1,000,000
Oct 03, 2023Anzu SPAC GP I LLC10 percent owner-C-ConversionSell2,490,000---
Oct 03, 2023Huskins Priya Cheriandirector-C-ConversionBuy25,000--25,000
Oct 03, 2023Huskins Priya Cheriandirector-C-ConversionSell25,000---
Oct 03, 2023Kantor Susandirector-C-ConversionBuy25,000-$2.5025,000

The last insider sell of Envoy Medical's stock was made by TAYLOR GLEN A on Dec 04 2023, selling 100,000 shares at $11.50 per share (valued at $1.15M). The last insider buy of ANZU was made by Lucas Brent T. on Nov 24 2023, buying 2,380 shares at $0.92 per share (worth $2.19K).

Envoy Medical Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 2027---
Q4 202391900.00%
Q3 202381266.67%
Q1 2023---
Q4 202221200.00%
Q1 2021-4-

0 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Envoy Medical's insiders, as of Q4 2027.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q4 2027---
Q4 20233--
Q3 20231--
Q1 2023---
Q4 2022---
Q1 2021---

As of Q4 2027, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Envoy Medical's stocks.

Envoy Medical Peer Ownership


TickerCompany
ARIZArisz Acquisition Corp.

ANZU Ownership FAQ


Envoy Medical is owned by institutional shareholders (28.27%), insiders (0.00%), and public (71.73%). The largest institutional shareholder of Envoy Medical is DEUTSCHE BANK AG\ (0% of total shares) and the top mutual fund owner is Keeley Funds, Inc. (0.08% of total shares).

Envoy Medical's major institutional shareholders are DEUTSCHE BANK AG\, FIR TREE CAPITAL MANAGEMENT LP, GEODE CAPITAL MANAGEMENT, LLC, POLAR ASSET MANAGEMENT PARTNERS INC., and WEISS ASSET MANAGEMENT LP. The top five shareholders own together 0% of the company's share outstanding.

As of Sep 2023, there are 16 institutional shareholders of Envoy Medical.

DEUTSCHE BANK AG\ owns 0 shares of Envoy Medical, representing 0% of the company's total shares outstanding, valued at $0 (as of Dec 2023).

As of Dec 2023, FIR TREE CAPITAL MANAGEMENT LP holds 0 shares of Envoy Medical (ANZU), compromising 0% of the company, valued at $0.

GEODE CAPITAL MANAGEMENT, LLC is the third largest holder of Envoy Medical. The company owns 0 of the company's shares outstanding (worth $0).